Proponents say the proposed regulation will give some consumers more affordable insurance options. Critics warn that the coverage could be less comprehensive.
Drugs that treat rheumatoid arthritis started out costing about $10,000 a year. Ten years later, they list for more than $40,000.
As biosimilar products reach the market and rival more established RA treatments, the players are exploring legal challenges involving antitrust and anti-competitive behavior.
The federal marketplace generally uses credit reports to help verify identities, but that doesn’t work if consumers have put a security freeze on them — as some did after the Equifax breach this year. Workarounds for this issue exist, but they make the process more time-consuming.
But buyer, beware. Cobbling together “packages” designed to cover gaps in high-deductible health plans could shortchange consumers, warn advocates.
As stopgap health plans gain attention as possible alternatives to Obamacare, consumers are advised to read the fine print.
Los promocionan como una alternativa económica a los planes de ACA. Pero expertos en mercados de seguros dudan sobre el tipo de cobertura que ofrecen.
Regulators are beginning to scrutinize claims by companies that their alternative plans help people meet Obamacare requirements.
With federal support slashed for organizations that provided consumers help in making their health plan choices, insurance brokers have to pick up the slack.
El período abierto de inscripción para las personas que compran su propio seguro de salud ya está en marcha, y termina el 15 de diciembre de 2017. Estos son cinco factores para tener en cuenta.
This year’s Obamacare open enrollment will be marked by a number of changes. KHN helps you navigate them.
Las medidas del presidente Donald Trump eliminan los reembolsos a las aseguradoras, pero no los subsidios que permiten a los consumidores pagar sus primas.
A quick guide to revisions to the cost-sharing subsidies for lower-income marketplace customers and the proposal to add different plans to the market.
But the approaches are not new and critics worry that these changes will leave some consumers with skimpier plans that expose them to high medical bills.
Both President Donald Trump and Sen. Rand Paul (R-Ky.) signaled last week that executive action was in the works that would give these plans a boost.
En la ciudad hay un solo centro de trauma, especializado en tratar a pacientes con lesiones severas producto de disparos, caídas o accidentes automovilísticos. Qué pasa a nivel nacional
Hospitals view adding trauma care as a potential profit tool, but experts say having more centers does not necessarily improve the system’s ability to respond to a mass casualty event.
The fate of the Affordable Care Act’s individual insurance marketplaces remains in play as state insurance commissioners take a central role in the debate.
The FDA granted approval for Spinraza in late December for use on children and adults with spinal muscular atrophy. Insurance coverage is mostly focused on infants and children.
KHN examines the role of PBMs in the prescription drug-pricing pipeline.